Generics makers appeal ruling on patents for Pozen's Treximet

09/8/2011 | MedCityNews.com

Alphapharm, Dr. Reddy's Laboratories and Par Pharmaceutical appealed a court decision that upholds patents covering Pozen's migraine drug Treximet. The ruling blocks FDA approval of the firms' generic versions before patent expiration.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA